RNA vaccine - aVaxziPen/Imperial College of Science
Alternative Names: Thermostable RNA vaccine - aVaxziPen/Imperial College LondonLatest Information Update: 19 Oct 2023
At a glance
- Originator Enesi Pharma; Imperial College of Science, Technology and Medicine
- Developer aVaxziPen; Imperial College of Science, Technology and Medicine
- Class COVID-19 vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research COVID 2019 infections